Loading…

Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam

This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary record 2018-11, Vol.183 (17), p.535-535
Main Authors: Achard, Damien, Caruso-Vares, Agathe, Collin, Jean-François, McKelvie, Joanne, Reddick, David, Ramage, Cliff
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163
cites cdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163
container_end_page 535
container_issue 17
container_start_page 535
container_title Veterinary record
container_volume 183
creator Achard, Damien
Caruso-Vares, Agathe
Collin, Jean-François
McKelvie, Joanne
Reddick, David
Ramage, Cliff
description This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P
doi_str_mv 10.1136/vr.104795
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2100334316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2100334316</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EokvhwAsgS3CAwxb_iePNEaoWkCohoYVrNHYmxSvHXuxk2zwKb4uXlB6Q4GR79Pu-mfFHyHPOzjiX9dtDOuOs0o16QFaCVWKta80ekhU73quGsRPyJOcdY6JRUjwmJ5Lxjao0X5Gf24QwDhhGGnuKt3tM7vgC72fqQjdZ7KiJBxeQJsx7l2CMaaadywgZC0LnOIVrasEfMNMbN36nQLML1x4pdIMLLo9F5GI4dgBq42BcuC_0PqYeg7PRUwgdHdDHW2dheEoe9eAzPrs7T8nXy4vt-cf11ecPn87fXa2N3CixtkLyziDTjVHQKFRyUwGXjRE91LoC2XPUuiyrTC-45VKC6BVDXbPKNryWp-T14rtP8ceEeWwHly16DwHjlFvBGZOykr_Rl3-huzilUKYrlGikZpqrQr1ZKJtizgn7dl_-FNLcctYe82oPqV3yKuyLO8fJDNjdk38CKoBYgBvncf63U_vtYvvl_SUTtRRF9GoRmWH3n-a_AE44rT0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2129370715</pqid></control><display><type>article</type><title>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Achard, Damien ; Caruso-Vares, Agathe ; Collin, Jean-François ; McKelvie, Joanne ; Reddick, David ; Ramage, Cliff</creator><creatorcontrib>Achard, Damien ; Caruso-Vares, Agathe ; Collin, Jean-François ; McKelvie, Joanne ; Reddick, David ; Ramage, Cliff</creatorcontrib><description>This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P&lt;0.001). Moreover, at the end of the study, a high clinical cure rate was observed in calves treated with FMC (100 per cent) or FFC (96.6 per cent) whereas cure was limited for calves receiving saline (29.6 per cent). Interestingly, calves treated with FMC were cured without relapse more rapidly compared with calves treated with FFC (HR=1.76, P&lt;0.05) and with a lower percentage of clinical relapse due to fever (P=0.05). These results underline the high efficacy of the FMC and are in line with the pharmacokinetic properties of florfenicol and meloxicam.</description><identifier>ISSN: 0042-4900</identifier><identifier>EISSN: 2042-7670</identifier><identifier>DOI: 10.1136/vr.104795</identifier><identifier>PMID: 30185471</identifier><language>eng</language><publisher>England: BMJ Publishing Group Limited</publisher><subject>Animals ; Antibiotics ; Antimicrobial agents ; Bacteria ; bovine respiratory disease ; Cattle ; Fever ; florfenicol ; inflammation ; meloxicam ; Pathogens ; Respiratory diseases ; treatment ; Veterinary medicine</subject><ispartof>Veterinary record, 2018-11, Vol.183 (17), p.535-535</ispartof><rights>British Veterinary Association 2018. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>British Veterinary Association 2018</rights><rights>2018 British Veterinary Association 2018. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</citedby><cites>FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30185471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Achard, Damien</creatorcontrib><creatorcontrib>Caruso-Vares, Agathe</creatorcontrib><creatorcontrib>Collin, Jean-François</creatorcontrib><creatorcontrib>McKelvie, Joanne</creatorcontrib><creatorcontrib>Reddick, David</creatorcontrib><creatorcontrib>Ramage, Cliff</creatorcontrib><title>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</title><title>Veterinary record</title><addtitle>Vet Rec</addtitle><description>This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P&lt;0.001). Moreover, at the end of the study, a high clinical cure rate was observed in calves treated with FMC (100 per cent) or FFC (96.6 per cent) whereas cure was limited for calves receiving saline (29.6 per cent). Interestingly, calves treated with FMC were cured without relapse more rapidly compared with calves treated with FFC (HR=1.76, P&lt;0.05) and with a lower percentage of clinical relapse due to fever (P=0.05). These results underline the high efficacy of the FMC and are in line with the pharmacokinetic properties of florfenicol and meloxicam.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>bovine respiratory disease</subject><subject>Cattle</subject><subject>Fever</subject><subject>florfenicol</subject><subject>inflammation</subject><subject>meloxicam</subject><subject>Pathogens</subject><subject>Respiratory diseases</subject><subject>treatment</subject><subject>Veterinary medicine</subject><issn>0042-4900</issn><issn>2042-7670</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi0EokvhwAsgS3CAwxb_iePNEaoWkCohoYVrNHYmxSvHXuxk2zwKb4uXlB6Q4GR79Pu-mfFHyHPOzjiX9dtDOuOs0o16QFaCVWKta80ekhU73quGsRPyJOcdY6JRUjwmJ5Lxjao0X5Gf24QwDhhGGnuKt3tM7vgC72fqQjdZ7KiJBxeQJsx7l2CMaaadywgZC0LnOIVrasEfMNMbN36nQLML1x4pdIMLLo9F5GI4dgBq42BcuC_0PqYeg7PRUwgdHdDHW2dheEoe9eAzPrs7T8nXy4vt-cf11ecPn87fXa2N3CixtkLyziDTjVHQKFRyUwGXjRE91LoC2XPUuiyrTC-45VKC6BVDXbPKNryWp-T14rtP8ceEeWwHly16DwHjlFvBGZOykr_Rl3-huzilUKYrlGikZpqrQr1ZKJtizgn7dl_-FNLcctYe82oPqV3yKuyLO8fJDNjdk38CKoBYgBvncf63U_vtYvvl_SUTtRRF9GoRmWH3n-a_AE44rT0</recordid><startdate>20181103</startdate><enddate>20181103</enddate><creator>Achard, Damien</creator><creator>Caruso-Vares, Agathe</creator><creator>Collin, Jean-François</creator><creator>McKelvie, Joanne</creator><creator>Reddick, David</creator><creator>Ramage, Cliff</creator><general>BMJ Publishing Group Limited</general><general>Blackwell Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20181103</creationdate><title>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</title><author>Achard, Damien ; Caruso-Vares, Agathe ; Collin, Jean-François ; McKelvie, Joanne ; Reddick, David ; Ramage, Cliff</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>bovine respiratory disease</topic><topic>Cattle</topic><topic>Fever</topic><topic>florfenicol</topic><topic>inflammation</topic><topic>meloxicam</topic><topic>Pathogens</topic><topic>Respiratory diseases</topic><topic>treatment</topic><topic>Veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Achard, Damien</creatorcontrib><creatorcontrib>Caruso-Vares, Agathe</creatorcontrib><creatorcontrib>Collin, Jean-François</creatorcontrib><creatorcontrib>McKelvie, Joanne</creatorcontrib><creatorcontrib>Reddick, David</creatorcontrib><creatorcontrib>Ramage, Cliff</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary record</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Achard, Damien</au><au>Caruso-Vares, Agathe</au><au>Collin, Jean-François</au><au>McKelvie, Joanne</au><au>Reddick, David</au><au>Ramage, Cliff</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam</atitle><jtitle>Veterinary record</jtitle><addtitle>Vet Rec</addtitle><date>2018-11-03</date><risdate>2018</risdate><volume>183</volume><issue>17</issue><spage>535</spage><epage>535</epage><pages>535-535</pages><issn>0042-4900</issn><eissn>2042-7670</eissn><abstract>This study was designed to evaluate the efficacy of a new florfenicol/meloxicam combination (FMC) in calves with bovine respiratory disease. A total of 90 young calves were challenged via intratracheal deposition of 108 colony-forming units of Mannheimia haemolytica. Data for 84 calves demonstrating a rectal temperature (RT) above 39.5°C and a combined total clinical score (TCS) greater than or equal to 3 were included. Calves were then randomly allocated to one of the three study groups (FMC; florfenicol/flunixin combination (FFC); or saline) and promptly treated. RT and TCS of calves treated with an FMC or FFC were consistently lower than RT and TCS of calves belonging to the control group (P&lt;0.001). Moreover, at the end of the study, a high clinical cure rate was observed in calves treated with FMC (100 per cent) or FFC (96.6 per cent) whereas cure was limited for calves receiving saline (29.6 per cent). Interestingly, calves treated with FMC were cured without relapse more rapidly compared with calves treated with FFC (HR=1.76, P&lt;0.05) and with a lower percentage of clinical relapse due to fever (P=0.05). These results underline the high efficacy of the FMC and are in line with the pharmacokinetic properties of florfenicol and meloxicam.</abstract><cop>England</cop><pub>BMJ Publishing Group Limited</pub><pmid>30185471</pmid><doi>10.1136/vr.104795</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0042-4900
ispartof Veterinary record, 2018-11, Vol.183 (17), p.535-535
issn 0042-4900
2042-7670
language eng
recordid cdi_proquest_miscellaneous_2100334316
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Antibiotics
Antimicrobial agents
Bacteria
bovine respiratory disease
Cattle
Fever
florfenicol
inflammation
meloxicam
Pathogens
Respiratory diseases
treatment
Veterinary medicine
title Treatment of experimentally induced bovine respiratory disease in young calves with a single administration of a combination of florfenicol and meloxicam
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A26%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20experimentally%20induced%20bovine%20respiratory%20disease%20in%20young%20calves%20with%20a%20single%20administration%20of%20a%20combination%20of%20florfenicol%20and%20meloxicam&rft.jtitle=Veterinary%20record&rft.au=Achard,%20Damien&rft.date=2018-11-03&rft.volume=183&rft.issue=17&rft.spage=535&rft.epage=535&rft.pages=535-535&rft.issn=0042-4900&rft.eissn=2042-7670&rft_id=info:doi/10.1136/vr.104795&rft_dat=%3Cproquest_cross%3E2100334316%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b3852-c231dbe079b5a95e5384a139b2fa674a3f1e775475bf21c133a2f50e7604c9163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2129370715&rft_id=info:pmid/30185471&rfr_iscdi=true